Compound A (CdpA) inhibits Skp2-mediated p27 ubiquitination and Skp2 E3 ligase activity by excluding Skp2 from the SCF complex, thus inducing G1/S cell-cycle arrest and tumor cell killing58. Here, KITLG is linked to neoplasm.